(Q34588134)

3 August 2017

title

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion (English)

1 reference

3 August 2017

1 reference

retinal vein occlusion

1 reference

Amelie Pielen

5

0 references

Bernhard Spitzer

object named as

Bernhard Spitzer

4

0 references

Nicolas Feltgen

3

object named as

Nicolas Feltgen

1 reference

3 August 2017

Gesine B Jaissle

1

1 reference

3 August 2017

Peter Szurman

2

1 reference

3 August 2017

Matus Rehak

6

1 reference

3 August 2017

Georg Spital

7

1 reference

3 August 2017

Heinrich Heimann

8

1 reference

3 August 2017

Carsten H Meyer

9

1 reference

3 August 2017

Retinal Vein Occlusion Study Group

10

1 reference

3 August 2017

publication date

18 August 2010

1 reference

Graefe's Archive for Clinical and Experimental Ophthalmology

3 August 2017

published in

1 reference

3 August 2017

volume

249

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

183-192

1 reference

https://scigraph.springernature.com/pub.10.1007/s00417-010-1470-2

3 August 2017

exact match

0 references

cites work

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal [...]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042100

One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042100

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042100

Bevacizumab in retinal vein occlusion-results of a prospective case series

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042100

Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042100

Errors in retinal thickness measurements obtained by optical coherence tomography

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042100

Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042100

Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042100

Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion

7 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion:results after 12 months and multiple regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Recommendation for the implementation of intravitreal injections--statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

The role of Stratus OCT in anti-VEGF therapy. Qualitative and quantitative assessment of neovascular AMD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Prognostic factors for retinal vein occlusion: prospective study of 175 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-010-1470-2

Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21337042

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00417-010-1470-2

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference